Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5
Fig 6
Effect of human recombinant CXCL5 (rh CXCL5) on PC cell motility.
PC cell motility was evaluated by Transwell migration and Transwell-Matrigel invasion assays. PC cells pretreated with rh CXCL5 (10 ng/ml) or vehicle for 12 hours. (a) Representative images of migrated cells. scale bars = 100 μm. (b) Quantitative data of migrated cells. (c) Quantitative data of invaded cells. Graphs show mean ± SE. *P < 0.05; **P<0.01.